Bayer AG, a German pharmaceutical and chemical company, is facing new challenges as it anticipates a decline in profits for the third consecutive year. The company is grappling with widespread legal disputes in the U.S., a steep drop in agricultural product prices, and increasing competition in the pharmaceutical market.

In the midst of intensifying trade tensions between the world's two largest economies, China is gearing up to implement countermeasures aimed at American agricultural exports. State-backed Global Times reports that these moves could significantly impact US agricultural products, further complicating the ongoing trade conflict between China and the United States.

Bunge Global SA $BG, a leading global trader in agricultural products, has projected a less favorable outlook for its profit this year. Amid escalating geopolitical uncertainty and volatile global commodity markets, the company anticipates its adjusted earnings for 2025 to drop to the lowest level since the onset of the pandemic.